20,500 Shares of Oscar Health, Inc. $OSCR Bought by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Oscar Health, Inc. (NYSE:OSCR) in the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 20,500 shares of the company’s stock, valued at approximately $632,000.

A number of other large investors have also recently modified their holdings of OSCR. Financial Management Professionals Inc. purchased a new position in shares of Oscar Health during the third quarter worth about $26,000. CoreCap Advisors LLC raised its stake in Oscar Health by 526.3% in the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after purchasing an additional 1,000 shares in the last quarter. GAMMA Investing LLC raised its stake in Oscar Health by 32.9% in the second quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock valued at $41,000 after purchasing an additional 357 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in Oscar Health in the first quarter valued at approximately $49,000. Finally, FNY Investment Advisers LLC bought a new stake in Oscar Health during the second quarter valued at approximately $57,000. Institutional investors own 75.70% of the company’s stock.

Key Oscar Health News

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Oscar reported Q3 adjusted earnings of $0.49 per share, versus analysts’ expected loss, and revenue of $5.14 billion, topping the $4.69 billion estimate and rising 72.1% year over year. Oscar Health beats Q3 earnings and revenue estimates
• Positive Sentiment: The company raised its 2026 revenue outlook to $19 billion–$19.3 billion, above the $18.64 billion FactSet estimate, and increased its full-year earnings outlook. Management cited improving medical costs and operating efficiencies as supporting margin gains, with expansion expected to contribute to 2027 growth. Q3 earnings call highlights outlook and margin gains
• Positive Sentiment: Operational indicators were also encouraging: membership increased 27.2% to 2.69 million, the medical loss ratio improved to 84.0%, and Oscar swung to a $167.3 million profit. Oscar Health Q3 revenue and membership growth
• Positive Sentiment: Zacks added OSCR to its Rank #1 (Strong Buy) growth-stocks list, reflecting favorable quantitative signals. Zacks growth stocks list
• Negative Sentiment: Piper Sandler lowered its price target from $48 to $45, although it maintained an Overweight rating. The new target still implies substantial upside from the referenced $30.74 share price. Piper Sandler rating information

Oscar Health Price Performance

Shares of NYSE OSCR traded down $2.44 during trading hours on Friday, reaching $30.74. 8,874,950 shares of the stock traded hands, compared to its average volume of 4,643,670. The company has a market capitalization of $9.49 billion, a P/E ratio of 12.70, a price-to-earnings-growth ratio of 0.34 and a beta of 2.56. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $38.50. The company’s 50-day simple moving average is $31.81 and its two-hundred day simple moving average is $23.97.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 5th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.63. The business had revenue of $5.14 billion during the quarter, compared to analyst estimates of $4.69 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. Oscar Health’s revenue for the quarter was up 72.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.53) earnings per share. Equities research analysts forecast that Oscar Health, Inc. will post 1.83 EPS for the current year.

Insider Activity

In other news, Director Mario Schlosser sold 600,000 shares of the business’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $30.34, for a total value of $18,204,000.00. Following the completion of the sale, the director directly owned 480,866 shares in the company, valued at approximately $14,589,474.44. The trade was a 55.51% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Vanessa Wittman sold 25,000 shares of the company’s stock in a transaction on Friday, September 18th. The shares were sold at an average price of $32.24, for a total transaction of $806,000.00. Following the completion of the sale, the director directly owned 112,121 shares of the company’s stock, valued at $3,614,781.04. This trade represents a 18.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 874,451 shares of company stock valued at $26,761,671. Insiders own 22.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on OSCR. Barclays boosted their price target on shares of Oscar Health from $39.00 to $49.00 and gave the stock an “overweight” rating in a research note on Thursday, September 17th. Bank of America raised their price objective on shares of Oscar Health from $28.00 to $30.00 and gave the company an “underperform” rating in a research report on Thursday, September 17th. Weiss Ratings raised shares of Oscar Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $34.00 price objective on shares of Oscar Health in a report on Thursday, September 17th. Finally, Raymond James Financial upped their target price on shares of Oscar Health from $34.00 to $42.00 and gave the stock an “outperform” rating in a research report on Friday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $34.60.

Oscar Health Profile

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act’s health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.